Introduction to Existing State Disclosure Laws and Regulations Summit on Disclosure, Transparency and Aggregate Spend For Drug, Device and Biotech Companies.
XBHR Annual Conference London 5-7 March 2014 1 Gerlind Wisskirchen, CMS Hasche Sigle Gunda Niehaus, Procter and Gamble David W. Garland, Epstein Becker.
Web hipaa hitech and privacy
Health Care in the Crosshairs: OSHA’s New Health Care Enforcement Initiative
OSHA’s New Enforcement Initiative: Targeting Inpatient Health Care Facilities and Nursing Homes
Taking Your Product to the U.S. Market: Health Regulatory Primer for Drugs and Devices Lynn Shapiro Snyder, Esq. Marcia Nusgart, R.Ph. Epstein Becker &
Preparing for and Managing an OSHA Inspection November 2, 2012 Eric J. Conn Head of the OSHA Practice Group at Epstein Becker & Green, P.C.
The ACA and What Comes Next 2014 EPSHRM BENEFITS CONFERENCE.
S ELF- D ISCLOSURE A DVANTAGES & P ITFALLS Carrie Valiant, Esq. Epstein Becker & Green, P.C. Washington, DC L. Lamar Blount, CPA Healthcare Management.
Aging in America: What Clients and Caregivers Need to Know Presented at the EmblemHealth Family Caregiving Summit Wednesday, April 30, 2014 PETER J. STRAUSS,
DRAFT FDASIA Committee Report David W. Bates MD, MSc, Chair 1.
Risk Assessments: Patient Safety and Innovation 28 June 2013.
